Page 101 - SRPSKO DRUŠTVO ISTRAŽIVAČA RAKA
P. 101

SDIRSACR                                                                                 Oncology Insights


        P02

        Inhibition of the membrane transporters in 5-fluorouracil-resistant colorectal cancer cells by chlorogenic
        acid


        Milena Milutinović, Anđela Andrejić, Milan Stanković, Danijela Nikodijević

        University of Kragujevac, Faculty of Science, Department of Biology and Ecology, Kragujevac, Republic of Serbia

        Keywords: ABC transporters, resistance, 5-fluorouracil


        Background: In the case of colorectal cancer, one of the most common and deadliest cancers, the commonly used
        chemotherapeutic agent is 5-fluorouracil (5-FU). However, a problem facing modern medicine is the development of
        resistance to chemotherapy in tumor cells. In several studies, chlorogenic acid (CHA), found in green tea and coffee
        extracts, has demonstrated a wide range of pharmacological actions, including anticancer effects. In our study, the
        potential of CHA to reverse the sensitivity of 5-FU-resistant colorectal cancer cells and inhibit the expression of key
        membrane transporters involved in the resistance development was investigated.
        Material and Methods: Human colon carcinoma (HCT-116) cell lines, resistant to 5-FU, were used as a model system.
        The cytotoxicity of 5-FU and the achieved resistance were determined using an MTT assay and expressed as IC50
        values and resistance factors for 24 h and 72 h. Effects of CHA on the expression of different ABC (ATP Binding Cassette)
        membrane transporters expressed in colon tissue were determined in HCT-116 5-FU resistant cells by qPCR methods.
        Results: Results show that CHA has the potential to inhibit the expression of some transporters on the transcriptional
        level in 5-FU resistant HCT-116 cells. The significant result is the reduced relative expression of MRP5 and MRP8
        membrane  transporters  in  resistant  cells  treated  with  CHA,  considering  that  these  transporters  were  included  in
        resistance development (their expression was increased in resistant cells compared to parental cells in our results).
        Conclusions: According to its inhibitory activity on expression of the key membrane transporters in the emergence of
        5-FU resistance in HCT-116 cells, chlorogenic acid should be further investigated for potential use to re-enhance the
        sensitivity of resistant cells to chemotherapeutics and inhibit their efflux. The effects on ABC transporter activity and
        more detailed experiments still need to be evaluated.

        Acknowledgments and funding: This work was supported by the Ministry of Education, Science and Technological
        Development of the Republic of Serbia (Agreement no. 451-03-65/2024-03/ 200122).





        P03

        The impact of silibinin on the expression of genes involved in the process of apoptosis in malignant cells
        treated with selective COX-2 inhibitor

        Vanesa Sekeruš  , Nebojša Pavlović  , Vesna Kojić  , Bojan Stanimirov  , Karmen Stankov  1
                      1,2
                                                     4
                                         3
                                                                      1
        1Department of Biochemistry, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
        2Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
        3Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
        4Faculty of Medicine, University of Novi Sad, Novi Sad; Oncology Institute of Vojvodina, Sremska Kamenica, Serbia

        Keywords: lung neoplasms; cyclooxygenase 2; celecoxib; silybin; apoptosis; carcinogenesis


        Background: Chronic inflammation and increased activity of the enzyme cyclooxygenase-2 (COX-2) are recognized as
        important factors in the etiopathogenesis of lung cancer. Celecoxib, a selective COX-2 inhibitor, is being considered as a
        potential agent in the prevention and therapy of lung cancer. The aim of this study was the in vitro determination of the
        cytotoxic effect of celecoxib and silibinin (silybin), a natural flavonolignan isolated from the plant Silybum marianum,
        on the human cell line of lung adenocarcinoma (A549), as well as an analysis of the expression of genes involved in
        inflammatory and apoptotic cell responses.
        Material and Methods: The cytotoxicity of celecoxib and silibinin on A549 cells was evaluated using dye exclusion
        and MTT assays. Quantification of gene expression was performed using the quantitative real-time polymerase chain
        reaction with reverse transcription (qRT-PCR), and was analyzed using the comparative ΔΔCt method, with ACTB as a

    86
   96   97   98   99   100   101   102   103   104   105   106